Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Prepaid Assets (2016 - 2025)

Seres Therapeutics (MCRB) has disclosed Prepaid Assets for 11 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 46.79% to $3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2025, down 46.79% year-over-year, with the annual reading at $3.1 million for FY2025, 46.79% down from the prior year.
  • Prepaid Assets hit $3.1 million in Q4 2025 for Seres Therapeutics, down from $3.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $15.2 million in Q1 2022 to a low of $2.4 million in Q2 2025.
  • Historically, Prepaid Assets has averaged $8.3 million across 5 years, with a median of $8.4 million in 2021.
  • Biggest five-year swings in Prepaid Assets: soared 131.96% in 2022 and later plummeted 62.33% in 2025.
  • Year by year, Prepaid Assets stood at $12.9 million in 2021, then rose by 3.88% to $13.4 million in 2022, then crashed by 40.04% to $8.0 million in 2023, then decreased by 27.78% to $5.8 million in 2024, then crashed by 46.79% to $3.1 million in 2025.
  • Business Quant data shows Prepaid Assets for MCRB at $3.1 million in Q4 2025, $3.1 million in Q3 2025, and $2.4 million in Q2 2025.